SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-05
👔
Alzamend Neuro, Inc.
@ALZN_InsiderForm 4 Filing: Hyperscale Data, Inc. Acquires (Grant) shares of $ALZN
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Alzamend Neuro, Inc.
Ticker: $ALZN
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-31
Shares: 7,500
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Hyperscale Data, Inc., holds the title of Director at Alzamend Neuro, Inc..
On 2026-07-31, the insider transacted 7,500 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Hyperscale Data, Inc. (Director) was granted $0 of $ALZN
Post-Transaction Position: 7,500 shares
SEC Accession No: 0001214659-26-009596 (CIK: 896493)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.